<DOC>
	<DOCNO>NCT02429505</DOCNO>
	<brief_summary>This study prospective observational study patient undergo treatment leishmaniasis miltefosine ( Impavido ) US weigh &gt; 75 kg volunteer provide information clinical response treatment 6 month start treatment .</brief_summary>
	<brief_title>Treatment Leishmaniasis With ImpavidoÂ® ( Miltefosine ) : Higher-Weight Patient Registry</brief_title>
	<detailed_description>Objective : The purpose observational study fulfill PMR 2127-4 miltefosine NDA ( 204684 ) : implement higher-weight-patient registry time period Mar 2015-Mar 2020 . Study Design : This study prospective observational study patient undergo treatment leishmaniasis Impavido US weigh &gt; 75 kg volunteer provide information clinical response treatment 6 month start treatment . Population : Leishmaniasis patient treat Impavido weigh 75 kg . Drug Product : Drug name : Impavido ( 50 mg capsule ) . Dosing regimen : per Impavido Product Label Study Procedures : Patients weigh 75 kg become aware Impavido Higher-Weight Patient Registry via Impavido website . By call 1-866-588-5405 , patient connect Impavido Higher-Weight Patient Registry Coordinating Center . A trained staff member acquaint patient goal procedure study . If patient tentatively agree participate study telephone , patient mail information form , Consent/Assent Forms , Consent patient 's physician release medical information . Receipt two sign Consent and/or Assent Forms Coordinating Center signify patient consent . The Coordinating Center contact patient 's physician end treatment , 1 , 3 , 6 month complete treatment , collect data efficacy adverse effect ( treatment ) . Sample Size Study Duration : Estimated 3-10 patient per year 5 year . Outcome Parameters : Efficacy Adverse effect Analysis : Baseline data , compliance prescribe treatment , outcomes report individual patient patient .</detailed_description>
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Miltefosine</mesh_term>
	<criteria>1 . Did subject give consent collect data physician ? 2 . Was subject treat leishmaniasis miltefosine ? 3 . Does subject weigh 75 kg ? [ none ]</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>